最新消息

First DES for Above-the-Knee Vascular Disease on the Horizon


說明
By L.A. McKeown
Tuesday, October 18, 2011
The first drug-eluting stent for the treatment of above-the-knee femoropopliteal artery disease is one step closer to availability in the United States following a unanimous (11-0) vote on October 13, 2011, by a US Food and Drug Administration (FDA) advisory panel.
 

"This is an important panel decision and I think it brings for the first time a biologic solution for restenosis of the peripheral vasculature," said William A. Gray, MD, of Columbia University Medical Center (New York, NY), in a telephone interview with TCTMD. “Obviously, the combination of the 2 data sets from the trial and the registry were compelling enough ...

相關附件 沒有附件

 

←回前頁 ↑回頂層